Irinotecan hydrochloride trihydrate
(CAS: 136572-09-3) |
SKU-Pack Size | Availability | Size | Price | |
EBC51163-1ML | In Stock | 1mL(10mM in DMSO) | €89.70 | |
EBC51163-100MG | In Stock | 100mg | €89.70 | |
EBC51163-200MG | In Stock | 200mg | €141.70 |
Please Select The Country You Are In To Find Your Local Distributor. |
Betaclonal | Phone£º+34 (0)91 471 6763 | |
29/1 Lomonosovsky Pr, | E-mail£ºtech@betaclonal.com | |
Spain | Madrid, Spain | Web£ºwww.betaclonal.com |
Product Information | |||||||||||||||||||||
Synonym(s) | Camptosar; Campto; CPT-11 | ||||||||||||||||||||
Chemical Name | (S)-4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl [1,4'-bipiperidine]-1'-carboxylate hydrochloride trihydrate | ||||||||||||||||||||
Application | Irinotecan hydrochloride trihydrate is an inhibitor of Topo I | ||||||||||||||||||||
CAS Number | 136572-09-3 | ||||||||||||||||||||
Purity | ¡Ý99.0% | ||||||||||||||||||||
Molecular Weight | 677.18 | ||||||||||||||||||||
Molecular Formula | C₃₃H₄₅ClN₄O₉ | ||||||||||||||||||||
SMILES | O=C(N1CCC(CC1)N2CCCCC2)OC3=CC4=C(CC)C5=C(C(N6C5)=CC(C7(CC)O)=C(COC7=O)C6=O)N=C4C=C3.Cl.O.O.O | ||||||||||||||||||||
Solubility | DMSO: 50 mg/mL (73.84 mM)
Water: 1.52 mg/mL (2.24 mM; Need ultrasonic and warming) |
||||||||||||||||||||
Preparing Stock Solutions |
|
||||||||||||||||||||
Shipping | Gel Pack | ||||||||||||||||||||
Storage | Store at -20¡ãC | ||||||||||||||||||||
Research Use | For Research Use Only. Not Intended for Diagnostic Or Therapeutic Use. |
Product Description | |
Irinotecan hydrochloride trihydrate, Irinotecan (CPT 11), a compound within the camptothecin family, is an inhibitor of Topo I (topoisomerase I) involved in cellular DNA replication and transcription. As a Topo I inhibitor, Irinotecan inhibits the religation step of the enzyme's normal action, inducing single stranded DNA breaks. These single stranded breaks are then converted to double-stranded breaks within the course of DNA replication which is reported to induce apoptosis or repair mechanisms as a result. Irinotecan is activated by esterases to produce the activated metabolite, SN 38 (sc-203697) and has been reported to be associated with cleavage of poly (ADP-ribose) polymerase (PARP) in colon carcinoma cells. Irinotecan's active metabolite SN 38 is additionally noted to activate p53 in the Huh7 cell line. |
Specific Protocols | |